Collagen Market

Gelatin still earns 58.4% of collagen revenue, yet collagen peptides are growing at 7.48% a year against 3.62% for gelatin, and that gap explains most of what happens to this industry by 2035. The Collagen Market covers gelatin, hydrolyzed collagen sold as collagen peptides, and native and medical-grade collagen, extracted from bovine, porcine, marine and poultry raw materials and sold to food, supplement, pharmaceutical, cosmetic and wound care buyers. Douglas Insights sizes it at USD 5.28 billion in 2025, built as 548,600 tonnes of shipped collagen multiplied by an average realised price of USD 9.62 per kilogram, and projects USD 8.86 billion by 2035, a 5.32% revenue CAGR. The defining recent move came on 12 May 2025, when Darling Ingredients and Tessenderlo Group agreed to combine Rousselot and PB Leiner into Nextida, a company with 23 plants and about 200,000 metric tons of gelatin and collagen capacity. The study belongs to our Functional Ingredients research, and every input is listed under the Douglas Insights research methodology.

Which collagen product type makes the money: gelatin, collagen peptides or native collagen?

Gelatin makes the most money in the collagen industry, at 58.4% of 2025 value or USD 3.08 billion, because confectionery, capsules and dairy use it by the tonne. Collagen peptides hold 34.9% and grow fastest, at 7.48% a year, on supplement and beauty demand.

Gelatin carries USD 3.08 billion because it is the volume product: gummy sweets, marshmallows, hard and soft pharmaceutical capsules and photographic and technical uses all buy it in bulk at the lowest price per kilogram. Its growth of 3.62% a year is the slowest of the three types, since food gelatin volumes follow population and confectionery output.

Collagen peptides are worth USD 1.84 billion in 2025 and reach USD 3.79 billion by 2035, the fastest rate at 7.48%. Hydrolysis cuts the protein into short chains that dissolve in cold water, so the peptides go into powders, drinks, bars and capsules sold for skin, joints and sports recovery. GELITA reported new clinical work on its BODYBALANCE bioactive collagen peptides for sports nutrition on 6 August 2026, according to its press page.

Native and medical-grade collagen adds USD 353.6 million, or 6.7%, and grows 6.35% a year. Undenatured type II collagen for joints, collagen sponges and dressings for wound care, dermal scaffolds and bioinks sell at many times the gelatin price, so a small tonnage carries a large value. Readers following the dressing side can compare our Wound Care Market study.

Which collagen source, bovine, porcine, marine or poultry, supplies each application?

Bovine material supplies the largest share of collagen in 2025, about 39.8% of tonnage by Douglas Insights estimates, because hides and bones are plentiful and acceptable to most religious diets. Porcine skins follow at roughly 31.4%.

By source, bovine hides and bones supply the largest collagen share, porcine skins follow, and marine collagen from fish skins and scales grows fastest because it serves buyers who avoid mammal sources. Poultry sternum cartilage is the main input for type II joint products. By application, Douglas Insights puts food and confectionery at 41.3% of 2025 collagen value, dietary supplements at 27.8%, pharmaceutical capsules at 14.6%, cosmetics at 9.9% and wound care plus other medical uses at 6.4%.

Why are collagen peptide powders and gummies pulling collagen demand ahead of food gelatin?

Collagen demand grows 3.15% a year in volume, and three drivers explain all of it: supplement peptides add 1.38 points, pharmaceutical and food gelatin adds 0.97 points and Asian consumption adds 0.80 points. Price adds a separate 2.10% a year.

Supplement peptides contribute 1.38 points. Darling Ingredients called collagen the fastest-growing area of its food segment when it announced the Nextida deal on 12 May 2025, and its second-quarter 2025 results of 24 July 2025 showed food segment net sales of USD 386.1 million and segment adjusted EBITDA of USD 69.9 million. A food segment margin of 18.1% tells you why producers are pushing tonnage out of commodity gelatin and into peptides. Collagen peptides sold as daily powders build repeat volume: one 10 gram serving a day is 3.65 kilograms of protein a year for each regular user. On that arithmetic, every 1 million new daily users adds about 3,650 tonnes of collagen peptide demand, or 0.67% of 2025 world tonnage.

Pharmaceutical and food gelatin contributes 0.97 points. Hard capsules, softgels and gummy vitamins all use gelatin as the shell or the gel, and supplement makers have been moving vitamins from tablets into gummies. Each gummy vitamin line adds gelatin tonnage at the low end of the price band, around USD 5.80 to USD 7.40 per kilogram, Douglas Insights estimates. Confectionery adds steady base load, and softgel capsules for fish oil and vitamin D keep pharmaceutical gelatin plants running near full shifts. The combined effect on collagen volume is close to one point a year, in line with packaged food and capsule output.

Asian consumption contributes 0.80 points. Japan has sold collagen drinks and peptide powders for decades, and the collagen buyer base in China, Korea and Southeast Asia keeps widening with beauty-from-within products. Douglas Insights calculates Asia Pacific collagen revenue growth at 6.84% a year, from USD 1.30 billion in 2025 to USD 2.52 billion in 2035, the fastest of the five regions. Nitta Gelatin, the Japanese gelatin and collagen peptide producer, reported results for the three months to 30 June 2026 in August 2026 on its investor site.

Add the three: 1.38 plus 0.97 plus 0.80 equals the 3.15-point volume leg, which lifts collagen shipments from 548,600 tonnes in 2025 to about 748,080 tonnes in 2035. Mix shift towards peptides then lifts the average price, which is why value grows faster than tonnage.

Which bottlenecks in bovine hide and pig skin supply restrain collagen growth?

Collagen growth loses about 0.95 points a year to three brakes: raw material supply tied to slaughter, plant-based substitutes and sourcing rules. Without them, Douglas Insights estimates gross collagen value growth near 6.3% a year instead of 5.32%.

Raw material removes 0.45 points. Collagen is a by-product: bovine hides, pig skins, bones and fish skins come only from animals slaughtered for meat or processed for fish fillets. A producer cannot buy more pig skin when peptide orders rise; it has to bid for it, and capacity of 200,000 metric tons at Nextida is a hard ceiling set by plant and supply, not by demand.

Substitutes remove 0.30 points. Pectin, agar, carrageenan and starch replace gelatin in vegan sweets and capsules, and fermentation start-ups are working on animal-free collagen proteins. Our Gelatin Substitutes Market report tracks that switch, which hits food gelatin tonnage first.

Sourcing rules remove 0.20 points. Halal, kosher and BSE controls narrow which collagen can go to which buyer, so porcine gelatin cannot serve many Middle Eastern and Southeast Asian markets and bovine material needs certified origin. Each restriction splits one collagen pool into several smaller ones, adding cost of roughly 2% to 4% for segregated lines, Douglas Insights estimates.

How much do buyers pay per kilogram of gelatin, collagen peptides and native collagen?

Collagen buyers paid an average of USD 9.62 per kilogram in 2025 across all types, Douglas Insights estimates, with food gelatin near the bottom of the band and native collagen at the top. That average rises 2.10% a year to about USD 11.84 by 2035.

Price bands differ sharply by collagen product. Food and pharmaceutical gelatin trades at roughly USD 5.80 to USD 8.90 per kilogram depending on bloom strength and certification. Collagen peptides fetch USD 11.50 to USD 19.00 per kilogram in bulk, and branded clinical peptide ingredients sell above that. Native type II collagen and medical-grade collagen run from USD 120 to more than USD 900 per kilogram, because doses are small and purity and sterility testing are strict.

The Nextida numbers offer an outside check on collagen pricing: about USD 1.5 billion of annual revenue across 200,000 metric tons of capacity works out to USD 7.50 per kilogram if the plants ran full. Our 9.62-dollar average sits 28.3% higher, which fits a world mix with more peptides and medical grades than a gelatin-heavy producer carries.

Shelf prices are another order of magnitude. A retail collagen peptide tub sells for many times its ingredient cost. That margin sits with brands.

Which collagen companies and gelatin producers control supply, and how concentrated is it?

Collagen supply is concentrated: Darling Ingredients says it produces about 30% of the world’s collagen, gelatin and hydrolyzed collagen combined, which Douglas Insights translates into roughly USD 1.58 billion of 2025 value. Douglas Insights estimates the top three producers hold 52.4% of revenue.

Darling Ingredients, through Rousselot, is the anchor of the collagen industry. Its announcement filed with the SEC on 12 May 2025 sets Nextida as 85% Darling and 15% Tessenderlo, with about USD 1.5 billion of revenue, 23 plants in South America, North America, Europe and Asia and closing expected in 2026. Tessenderlo brings PB Leiner, a long-standing gelatin and collagen producer, into the venture.

GELITA, based in Eberbach, Germany, describes itself as a global supplier of gelatin and collagen peptides and builds its position on clinically tested branded peptides such as BODYBALANCE and CURADERM. According to its press page, GELITA raised its shareholding in SelJel to near-full ownership on 26 August 2026 and signed a bioink research agreement with Black Drop on 3 March 2026.

Weishardt, founded in 1839 in Dijon, runs 4 production plants with 430 employees and exports 85% of its sales, according to its company page; its Naticol marine collagen peptides serve supplement and nutricosmetic buyers. Nitta Gelatin covers gelatin and collagen peptides from Japan. Douglas Insights puts Nextida alone near 33.1% of 2025 collagen value once PB Leiner is added to Rousselot, GELITA at about 12.6% and the next three producers together near 15.0%.

Where is collagen consumed: Europe, North America or Asia Pacific?

Europe leads collagen with USD 1.79 billion, or 33.9% of 2025 value, because the largest gelatin plants and pharmaceutical capsule makers sit there. North America follows closely, and Asia Pacific grows fastest at 6.84% a year.

Europe grows 4.21% a year to USD 2.70 billion by 2035, slowed by mature gelatin demand but supported by German, French and Benelux producers. North America holds USD 1.67 billion in 2025 and reaches USD 2.73 billion at 5.02%, carried by collagen peptide powders and the largest supplement retail channel.

Asia Pacific holds USD 1.30 billion and is the fastest-growing region at 6.84% a year, because collagen drinks and powders are mainstream beauty products in Japan and Korea and are spreading in China. Latin America adds USD 332.5 million at 5.97%, and Brazil and Argentina also matter as hide suppliers for the whole industry. Middle East and Africa is the wildcard: USD 184.6 million in 2025, growing 5.54% a year, with halal bovine and marine collagen the only routes in for most buyers.

Readers comparing consumer pull can also see our Beauty Supplements Market and Nutraceutical Products Market studies, where collagen peptides are one of the leading ingredients.

Which collagen hygiene rules and gelatin sourcing standards must producers comply with?

Collagen and gelatin for food in Europe fall under Regulation (EC) No 853/2004, adopted on 29 April 2004, which lays down specific hygiene rules for food of animal origin. Every collagen plant selling into the EU must therefore trace raw material back to fit animals.

For buyers, that rule means hides, skins and bones used for collagen must come from slaughtered animals fit for human consumption, with approved plants and documented processing. Pharmaceutical gelatin adds BSE and transmissible spongiform encephalopathy (TSE) risk controls, and halal or kosher certification decides which collagen can go to which customer. Compliance cost is one of the reasons small collagen producers struggle to compete with the 23-plant Nextida network.

What if collagen peptide growth runs faster or slower to 2035?

The collagen base case reaches USD 8.86 billion in 2035, with a slower case of USD 7.54 billion and a faster case of USD 10.40 billion. Volume growth from 2.20% to 4.10% a year explains most of that spread.

The slower case pairs 2.20% volume with 1.40% price, a 3.63% CAGR, if hide supply tightens and food makers move faster to plant gels. The faster case takes 4.10% volume and 2.80% price, a 7.01% CAGR, if collagen peptides keep gaining in supplements and Asia. A one-point rise in collagen tonnage growth adds about USD 897.3 million to the 2035 value, while a one-point cut removes about USD 822.3 million.

Published collagen forecasts run between 5.3% and 6.32% a year, and our 5.32% base sits in the lower half of that range, because we count gelatin tonnage at its real low price. The Nextida deal signed on 12 May 2025 is a base-case assumption: if closing slips past 2026, consolidation gains arrive later, and the slower path becomes more likely.

Douglas Exclusive: the Collagen Capacity Register

The Collagen Capacity Register is a Douglas Insights model, not an official list, built from 13 disclosed inputs. Those inputs come from company filings and company pages: Darling’s 30% world share, Nextida’s 23 plants, 200,000 metric tons and USD 1.5 billion, the 85% and 15% ownership split, Darling’s food segment sales of USD 386.1 million and EBITDA of USD 69.9 million, Weishardt’s 4 plants, 430 employees and 85% export share, and GELITA’s two dated 2026 moves.

The register shows the scale gap in collagen manufacturing. An average Nextida plant handles about 8,696 tonnes and earns about USD 65.2 million a year, while a four-plant specialist such as Weishardt competes on marine peptides and service rather than tonnage. Our finding: collagen pricing power sits with whoever controls hides and skins at scale, and the specialists win only where a branded peptide or a marine source earns a premium of USD 3 or more per kilogram.

How the model turns 548,600 tonnes of collagen into USD 5.28 billion?

Collagen revenue equals 548,600 tonnes multiplied by USD 9.62 per kilogram, giving USD 5.28 billion for 2025. The tonnage starts from Darling’s statement that it makes about 30% of the world’s collagen and from Nextida capacity of 200,000 metric tons.

Forward, 548,600 tonnes growing 3.15% a year reach about 748,080 tonnes in 2035, and USD 9.62 per kilogram growing 2.10% reaches USD 11.84; the product is USD 8.86 billion. The model covers 5 regions and draws on 5 company sources, 1 EU regulation and 4 published growth rates.

Cross-checks: the three product rows sum to USD 8.84 billion in 2035, within 0.19% of the total, and the five regions reconcile exactly to the global row. Darling’s 30% share of USD 5.28 billion equals USD 1.58 billion, within 5.6% of the USD 1.5 billion Nextida revenue that also includes PB Leiner.

What should gelatin buyers, collagen peptide brands and investors take from these numbers?

Collagen buyers should plan on 5.32% annual value growth, with the money moving from gelatin to collagen peptides at 7.48% a year. Secure hide, skin and fish skin supply before 2027.

Peptide brands gain most from clinical claims, as GELITA’s 2026 study work shows. Investors should watch Nextida closing, which would put about one third of world collagen value under one roof. Food makers using gelatin should test plant gels for at least 10% of volume as a hedge against hide prices.

Sources

1. SEC EDGAR Darling Ingredients and Tessenderlo Group agree to form Nextida (EX-99.1) (2025)
2. Darling Ingredients Darling Ingredients second quarter 2025 results (2025)
3. GELITA GELITA press releases (2026)
4. Weishardt About Weishardt (2026)
5. EUR-Lex Regulation (EC) No 853/2004 (2004)
6. Nitta Gelatin Nitta Gelatin investor site (2026)